טוען...
A validated stability indicating HPTLC method for simultaneous estimation of irbesartan and hydrochlorothiazide
INTRODUCTION: Irbesartan, a diazaspiro angiotensin II blocker, is marketed in combination with Hydrochlorothiazide, which is a diuretic acting on distal convoluted tubule; for synergistic anti-hypertensive action. The present study deals with development and validation of a stability indicating HPTL...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Medknow Publications & Media Pvt Ltd
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3658016/ https://ncbi.nlm.nih.gov/pubmed/23781414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-4708.72229 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|